February 4, 2022
Terminal Complement Complex (TCC) ELISA Now Available
ALPCO now offers an ELISA to measure the concentration of TCC (sC5b-9) levels in human plasma; an essential step to evaluate whether foreign materials in contact with blood are triggering an immune response. The Complement TCC ELISA is easy-to-use with a 2-hour incubation and reflects complement activation regardless of pathway.
The Complement System TCC ELISA is a flexible and easy to use enzyme immunoassay for determination of the terminal complement complex (TCC, also known as sC5b-9) in human plasma.
Key Features:
- Broad Application: TCC is an universal complement activity marker that allows assessment of an activated complement system for conditions independent of activation pathway.
- Simplified Workflow: The Complement System TCC assay include ready-to-use reagents and offers short incubation times reducing hands-on-time and simplifying workflows.
- Well-published Biomarker: TCC has been used for over 30 years as a complement activity biomarker in research and drug development.